Pfizer Inc Closed Now

Overview & Vision

Pfizer Inc. is a leading global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering innovative medicines and vaccines. The company’s vision is “Breakthroughs that change patients’ lives”, focusing on advancing scientific research to address some of the world’s most challenging health problems.

History & Development

Founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York, the company initially produced a palatable form of an antiparasitic drug. Over the decades, Pfizer expanded its research capabilities, becoming a pioneer in antibiotics, vaccines, and numerous therapeutic areas. The company gained global attention for developing the first widely authorized COVID-19 vaccine in collaboration with BioNTech in 2020.

Products & Therapeutic Areas

Pfizer’s portfolio spans a wide range of healthcare needs, including:

• Vaccines: Comirnaty (COVID-19), Prevnar family (pneumococcal disease)

• Oncology: Ibrance, Xtandi, Inlyta

• Cardiovascular & Metabolic: Eliquis, Lipitor

• Immunology & Inflammation: Xeljanz

• Rare Diseases: Vyndaqel, Talzenna

• Anti-Infectives: Zyvox, Zithromax

Innovation & Research

Pfizer invests billions annually in R&D to advance precision medicine, mRNA technology, and digital health solutions. Its research spans more than 10 therapeutic areas, with clinical trials conducted worldwide. The company also actively pursues partnerships with biotech firms and academic institutions.

Sustainability & Corporate Responsibility

Pfizer focuses on equitable access to medicines, aiming to provide its full portfolio of innovative medicines and vaccines to 45 low-income countries on a not-for-profit basis by 2025. Environmental goals include reducing greenhouse gas emissions and increasing sustainable manufacturing practices.

Global Reach & Competitive Position

Operating in more than 125 countries, Pfizer maintains manufacturing and R&D facilities worldwide. The company competes with other pharmaceutical giants such as Merck, Johnson & Johnson, and Moderna, maintaining a strong position in vaccines, oncology, and specialty medicines.